Tenon Medical, Inc. (NASDAQ:TNON – Get Free Report)’s share price was down 2.4% during trading on Wednesday . The company traded as low as $0.76 and last traded at $0.76. Approximately 13,263 shares traded hands during trading, a decline of 90% from the average daily volume of 136,713 shares. The stock had previously closed at $0.78.
Analysts Set New Price Targets
Separately, Benchmark dropped their price target on shares of Tenon Medical from $5.00 to $3.00 and set a “speculative buy” rating on the stock in a research note on Monday, April 15th.
Read Our Latest Stock Report on TNON
Tenon Medical Stock Performance
Tenon Medical (NASDAQ:TNON – Get Free Report) last issued its quarterly earnings data on Tuesday, May 14th. The company reported ($1.25) earnings per share for the quarter. The company had revenue of $0.72 million for the quarter. Tenon Medical had a negative return on equity of 1,267.31% and a negative net margin of 445.77%.
Tenon Medical Company Profile
Tenon Medical, Inc, a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints.
Featured Articles
- Five stocks we like better than Tenon Medical
- About the Markup Calculator
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- This Financial Stock’s Earnings Signal a Buying Opportunity
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Tenon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenon Medical and related companies with MarketBeat.com's FREE daily email newsletter.